Search research articles
Contact Us
Filters
Showing results (1451-1460 of 1,553) with videos related to
Page
of 156
Sort By:
Lancet (London, England)
|
October 23, 2023
Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial
Yelena Y Janjigian, Akihito Kawazoe, Yuxian Bai, et al.
Lancet (London, England)
|
June 1, 2026
Perioperative serplulimab with neoadjuvant chemotherapy versus perioperative chemotherapy in PD-L1-positive gastric cancer (ASTRUM-006): a randomised, double-blind, multicentre, phase 3 study
Lin Shen, Xiaotian Zhang, Ke Ji, et al.
Medicine
|
February 18, 2016
Differences and Similarities in the Clinicopathological Features of Pancreatic Neuroendocrine Tumors in China and the United States: A Multicenter Study
Li-Ming Zhu, Laura Tang, Xin-Wei Qiao, et al.
The Journal of Cell Biology
|
January 21, 2021
CEP55 promotes cilia disassembly through stabilizing Aurora A kinase
Yu-Cheng Zhang, Yun-Feng Bai, Jin-Feng Yuan, et al.
Infection and Immunity
|
January 16, 2019
Structural and Functional Insights into PpgL, a Metal-Independent β-Propeller Gluconolactonase That Contributes to <i>Pseudomonas aeruginosa</i> Virulence
Ying-Jie Song, Kai-Lun Wang, Ya-Lin Shen, et al.
Journal for Immunotherapy of Cancer
|
March 23, 2026
Fecal microbiota transplantation combined with anti-PD-1 therapy in refractory microsatellite-stable gastric cancer: a phase I feasibility and safety study
Yifan Zhang, Xiaomin Xu, Shulin Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 18, 2013
Everolimus for previously treated advanced gastric cancer: results of the randomized, double-blind, phase III GRANITE-1 study
Atsushi Ohtsu, Jaffer A Ajani, Yu-Xian Bai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 3, 2021
Avapritinib Versus Regorafenib in Locally Advanced Unresectable or Metastatic GI Stromal Tumor: A Randomized, Open-Label Phase III Study
Yoon-Koo Kang, Suzanne George, Robin L Jones, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 12, 2025
Fruquintinib in less pretreated patients: Multivariate profile-matching analysis of FRESCO-2 to FRESCO
Arvind Dasari, Cathy Eng, Sara Lonardi, et al.
BMJ (Clinical Research Ed.)
|
March 12, 2026
Camrelizumab plus CAPOX with camrelizumab based maintenance versus CAPOX alone as initial treatment for gastric or gastro-oesophageal junction adenocarcinoma: randomised phase 3 trial
Zhi Peng, Yanqiao Zhang, Huiting Xu, et al.
Page
of 156
Search research articles
Search
Showing results (1451-1460 of 1,553) with videos related to
Sort By:
Page
of 156
Lancet (London, England)
|
October 23, 2023
Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial
Yelena Y Janjigian, Akihito Kawazoe, Yuxian Bai, et al.
Lancet (London, England)
|
June 1, 2026
Perioperative serplulimab with neoadjuvant chemotherapy versus perioperative chemotherapy in PD-L1-positive gastric cancer (ASTRUM-006): a randomised, double-blind, multicentre, phase 3 study
Lin Shen, Xiaotian Zhang, Ke Ji, et al.
Medicine
|
February 18, 2016
Differences and Similarities in the Clinicopathological Features of Pancreatic Neuroendocrine Tumors in China and the United States: A Multicenter Study
Li-Ming Zhu, Laura Tang, Xin-Wei Qiao, et al.
The Journal of Cell Biology
|
January 21, 2021
CEP55 promotes cilia disassembly through stabilizing Aurora A kinase
Yu-Cheng Zhang, Yun-Feng Bai, Jin-Feng Yuan, et al.
Infection and Immunity
|
January 16, 2019
Structural and Functional Insights into PpgL, a Metal-Independent β-Propeller Gluconolactonase That Contributes to <i>Pseudomonas aeruginosa</i> Virulence
Ying-Jie Song, Kai-Lun Wang, Ya-Lin Shen, et al.
Journal for Immunotherapy of Cancer
|
March 23, 2026
Fecal microbiota transplantation combined with anti-PD-1 therapy in refractory microsatellite-stable gastric cancer: a phase I feasibility and safety study
Yifan Zhang, Xiaomin Xu, Shulin Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 18, 2013
Everolimus for previously treated advanced gastric cancer: results of the randomized, double-blind, phase III GRANITE-1 study
Atsushi Ohtsu, Jaffer A Ajani, Yu-Xian Bai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 3, 2021
Avapritinib Versus Regorafenib in Locally Advanced Unresectable or Metastatic GI Stromal Tumor: A Randomized, Open-Label Phase III Study
Yoon-Koo Kang, Suzanne George, Robin L Jones, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 12, 2025
Fruquintinib in less pretreated patients: Multivariate profile-matching analysis of FRESCO-2 to FRESCO
Arvind Dasari, Cathy Eng, Sara Lonardi, et al.
BMJ (Clinical Research Ed.)
|
March 12, 2026
Camrelizumab plus CAPOX with camrelizumab based maintenance versus CAPOX alone as initial treatment for gastric or gastro-oesophageal junction adenocarcinoma: randomised phase 3 trial
Zhi Peng, Yanqiao Zhang, Huiting Xu, et al.
Page
of 156